A citation-based method for searching scientific literature

Xiao Li, Ran You, Xinwei Wang, Congxin Liu, Zicheng Xu, Jin Zhou, Bin Yu, Ting Xu, Hongzhou Cai, Qing Zou. Clin Cancer Res 2016
Times Cited: 67



Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard, Rosemarie Davidson, Diana Eccles, Trevor Cole, Jackie Cook, Carole Brewer, Marc Tischkowitz, Fiona Douglas, Shirley Hodgson, Lisa Walker, Mary E Porteous, Patrick J Morrison, Lucy E Side, M John Kennedy, Catherine Houghton, Alan Donaldson, Mark T Rogers, Huw Dorkins, Zosia Miedzybrodzka, Helen Gregory, Jacqueline Eason, Julian Barwell, Emma McCann, Alex Murray, Antonis C Antoniou, Douglas F Easton. J Natl Cancer Inst 2013
Times Cited: 487




List of shared articles



Times cited

Genetic Factors in the Locoregional Management of Breast Cancer.
Bruce G Haffty, David M Euhus, Lori J Pierce. J Clin Oncol 2020
2

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients.
Jinsun Woo, Geumhee Gwak, Inseok Park, Byung Noe Bae, Se Kyung Lee, Byung Joo Chae, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam,[...]. Sci Rep 2021
0

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Nadine M Tung, Judy C Boughey, Lori J Pierce, Mark E Robson, Isabelle Bedrosian, Jill R Dietz, Anthony Dragun, Judith Balmana Gelpi, Erin W Hofstatter, Claudine J Isaacs,[...]. J Clin Oncol 2020
53

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
34

Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
Haitham W Tuffaha, Andrew Mitchell, Robyn L Ward, Luke Connelly, James R G Butler, Sarah Norris, Paul A Scuffham. Genet Med 2018
36


Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
Ye-Lei Xiao, Kang Wang, Qiang Liu, Jie Li, Xiang Zhang, Hong-Yuan Li. Clin Breast Cancer 2019
11

Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
Ruta Marcinkute, Emma Roisin Woodward, Ashu Gandhi, Sacha Howell, Emma J Crosbie, Julie Wissely, James Harvey, Lindsay Highton, John Murphy, Cathrine Holland,[...]. J Med Genet 2021
0

Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
Davide Angeli, Samanta Salvi, Gianluca Tedaldi. Int J Mol Sci 2020
17

BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.
Filipa Lynce, Ilana Schlam, Xue Geng, Beth N Peshkin, Sue Friedman, Julie Dutil, Zeina Nahleh, Claudia Campos, Charité Ricker, Patricia Rodriguez,[...]. J Genet Couns 2021
0